Initial clinical study clone anticarcinoembryonic antigen antibody patients colorectal cancer murine monoclonal antibody carcinoembryonic antigen CEA means benzylisothiocyanate derivative diethylenetriamine penta-acetic acid DTPA clinical radioimmunodetection studies patients history colorectal cancer serum CEA levels suggestive tumor recurrence Patients minutes mg monoclonal antibody mCi mean radiochemical purity toxicity stability radiolabel antibody patient serum high-performance liquid chromatography HPLC sodium dodecyl sulfate-polyacrylamide gel electrophoresis SDS-PAGE autoradiography immunoprecipitation hours infusion Tumor sites patients Sites antibody accumulation patients tumor resection laparotomy patients fine-needle biopsy patients Nine patients lesion irradiated return serum CEA antigen level normal normal values absence high levels CEA ng/mL disappearance radioactivity patient serum first order elimination kinetics mean half-life hours serum half-life dose antibody serum CEA titers ng/mL mean liver uptake dose ID hours administration hepatic metastases areas increased uptake radioactivity Radioimmunodetection recurrent colorectal cancer computed tomographic CT scans achievable agent successful clinical intervention patients 